Thromboembolic events in patients with SARS-CoV-2

J Vasc Surg. 2020 Aug;72(2):760-761. doi: 10.1016/j.jvs.2020.04.488. Epub 2020 Apr 30.

Authors

Jun Jie Ng¹, Andrew M T L Choong²

Affiliations

¹ SingVaSC, Singapore Vascular Surgical Collaborative, Singapore; Department of Surgery, Yong Loo Lin School of Medicine, Singapore; Division of Vascular and Endovascular Surgery, National University Heart Centre, Singapore.
² SingVaSC, Singapore Vascular Surgical Collaborative, Singapore; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Cardiovascular Research Institute, National University of Singapore, Singapore; Division of Vascular and Endovascular Surgery, National University Heart Centre, Singapore.

No abstract available

Publication types

Letter

MeSH terms

Administration, Intravenous
Betacoronavirus / isolation & purification
Betacoronavirus / pathogenicity*
Blood Coagulation / physiology
COVID-19
Coronavirus Infections / blood
Coronavirus Infections / complications*
Coronavirus Infections / epidemiology
Coronavirus Infections / virology
Humans
Incidence
Intensive Care Units / statistics & numerical data
Observational Studies as Topic
Pandemics
Patient Admission / statistics & numerical data
Pneumonia, Viral / blood
Pneumonia, Viral / complications*
Pneumonia, Viral / epidemiology
Pneumonia, Viral / virology
SARS-CoV-2
Thromboembolism / epidemiology*
Thromboembolism / etiology
Thromboembolism / physiopathology
Thromboembolism / therapy
Tissue Plasminogen Activator / administration & dosage
Treatment Outcome

Substances

Tissue Plasminogen Activator